Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectr
Author: ["Sam E Day","Mikko I Kettunen","Ferdia A Gallagher","De-En Hu","Mathilde Lerche","Jan Wolber","Klaes Golman","Jan Henrik Ardenkjaer-Larsen","Kevin M Brindle"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Measurements of early tumor responses to therapy have been shown, in some cases, to predict treatment outcome. We show in lymphoma-bearing mice injected intravenously with hyperpolarized [1-13C]pyruvate that the lactate dehydrogenase–catalyzed flux of 13C label between the carboxyl groups of pyruvate and lactate in the tumor can be measured using 13C magnetic resonance spectroscopy and spectroscopic imaging, and that this flux is inhibited within 24 h of chemotherapy. The reduction in the measured flux after drug treatment and the induction of tumor cell death can be explained by loss of the coenzyme NAD(H) and decreases in concentrations of lactate and enzyme in the tumors. The technique could provide a new way to assess tumor responses to treatment in the clinic.
Cite this article
Day, S., Kettunen, M., Gallagher, F. et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 13, 1382–1387 (2007). https://doi.org/10.1038/nm1650
